Scott Askin

491 total citations
5 papers, 287 citations indexed

About

Scott Askin is a scholar working on Public Health, Environmental and Occupational Health, Physiology and Economics and Econometrics. According to data from OpenAlex, Scott Askin has authored 5 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Public Health, Environmental and Occupational Health, 3 papers in Physiology and 3 papers in Economics and Econometrics. Recurrent topics in Scott Askin's work include Ethics in Clinical Research (3 papers), Biomedical Ethics and Regulation (3 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Scott Askin is often cited by papers focused on Ethics in Clinical Research (3 papers), Biomedical Ethics and Regulation (3 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Scott Askin collaborates with scholars based in Switzerland, Netherlands and United Kingdom. Scott Askin's co-authors include Francesca Cerreta, Armin Ritzhaupt, Tim De Smedt, Ghislaine J. M. W. van Thiel, Yared Santa‐Ana‐Téllez, Helga Gardarsdóttir, Mira G. P. Zuidgeest, Anthonius de Boer, Spiros Vamvakas and Thomas Ganslandt and has published in prestigious journals such as Nature Reviews Drug Discovery, Clinical Pharmacology & Therapeutics and BMC Medical Research Methodology.

In The Last Decade

Scott Askin

5 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott Askin Switzerland	5	76	68	50	38	38	5	287
Samuel Whipple United States	5	56 0.7×	44 0.6×	90 1.8×	14 0.4×	27 0.7×	9	312
Arturo López Pineda United States	8	59 0.8×	60 0.9×	52 1.0×	15 0.4×	82 2.2×	16	366
Michaela Th. Mayrhofer Netherlands	10	139 1.8×	86 1.3×	19 0.4×	11 0.3×	31 0.8×	28	325
Ken Getz United States	9	84 1.1×	25 0.4×	44 0.9×	11 0.3×	32 0.8×	20	234
Natalia Norori United Kingdom	4	47 0.6×	198 2.9×	16 0.3×	40 1.1×	26 0.7×	8	421
Melissa Rammage United States	7	57 0.8×	69 1.0×	19 0.4×	13 0.3×	21 0.6×	9	275
Chaohui Guo China	11	69 0.9×	22 0.3×	47 0.9×	14 0.4×	17 0.4×	46	427
Julian Saß Germany	5	82 1.1×	67 1.0×	15 0.3×	22 0.6×	58 1.5×	15	324
Andrea Essenwanger Germany	4	79 1.0×	66 1.0×	14 0.3×	22 0.6×	51 1.3×	6	304

Countries citing papers authored by Scott Askin

Since Specialization

Citations

This map shows the geographic impact of Scott Askin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Askin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Askin more than expected).

Fields of papers citing papers by Scott Askin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Askin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Askin. The network helps show where Scott Askin may publish in the future.

Co-authorship network of co-authors of Scott Askin

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Askin. A scholar is included among the top collaborators of Scott Askin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Askin. Scott Askin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Askin, Scott, et al.. (2023). Artificial Intelligence Applied to clinical trials: opportunities and challenges. Health and Technology. 13(2). 203–213. 132 indexed citations

2.

Askin, Scott, Shibeshih Belachew, Timothy Kilchenmann, et al.. (2023). Evolving regulatory perspectives on digital health technologies for medicinal product development. npj Digital Medicine. 6(1). 56–56. 32 indexed citations

3.

Zuidgeest, Mira G. P., Ghislaine J. M. W. van Thiel, Scott Askin, et al.. (2022). Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective. Clinical Pharmacology & Therapeutics. 112(2). 344–352. 55 indexed citations

4.

Cerreta, Francesca, et al.. (2020). Digital technologies for medicines: shaping a framework for success. Nature Reviews Drug Discovery. 19(9). 573–574. 32 indexed citations

5.

Bruland, Philipp, Mark McGilchrist, Éric Zapletal, et al.. (2016). Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting. BMC Medical Research Methodology. 16(1). 159–159. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact